Tirzepatide Pronunciation in English: How to Say It Correctly

The most common mistake, and why it sticks

The usual error is treating tirzepatide as five syllables: people insert an extra vowel sound and say something like "tir-zee-PAT-ih-tide". It's an understandable stumble; the letter string irze doesn't appear often in English. The actual shape is simpler: tir-ZEP-a-tide. Say "zip" and then soften it slightly to "zep"; add "tir" before it and "a-tide" after, and you're there. Once you've heard a clinician say it, the mispronunciation usually disappears for good.

This matters more than it might seem. If you're speaking with a GP, a pharmacist or a prescriber and you want to ask about your treatment, using the right name avoids any brief confusion, particularly if a doctor also hears it referred to by its brand. The tirzepatide overview on this site covers the medicine in full, but the name itself is worth locking in first.

One misconception worth letting go gently: some people assume the word has a Latin or Greek root they should already know. It doesn't work that way. INN drug names are constructed systematically, not derived from classical vocabulary, so there's no reason it should feel familiar before you've looked it up.

Breaking tirzepatide down phonetically

Written out for English speakers: tir – ZEP – uh – tyde. Each part:

Tir: rhymes with "stir" or "fir". Short, clipped.
ZEP: the stressed syllable; sounds like "zep" as in "zeppelin" minus the second half.
uh: a brief, unstressed schwa, the same sound as the "a" in "about".
tyde: rhymes with "tide" or "wide".

Put together at normal speech pace: tir-ZEP-uh-tyde. The dedicated pronunciation guide on this site includes audio-style syllable breakdowns that can help if you'd rather see it mapped out in more detail.

The INN suffix -tide signals a peptide-based compound; once you know that, you'll spot it in other drug names too. Understanding the naming logic is occasionally handy when reading a prescription label or a patient information leaflet, both of which refer to the medicine by its INN rather than its brand name.

Brand name versus active ingredient: Mounjaro and tirzepatide

Tirzepatide is the active ingredient. Mounjaro is the trade name Eli Lilly markets it under in the UK. In practice, prescriptions may be written either way, and the patient information leaflet inside the box uses both. The Mounjaro pronunciation page walks through the brand name separately if you want both clear at once.

Knowing the INN is useful beyond conversations with your doctor. If you're researching clinical trial data or reading NICE guidance, the documents use "tirzepatide" throughout, not "Mounjaro". NICE's appraisal of tirzepatide (TA1026, published in December 2024 and updated September 2025) refers exclusively to the INN. The same applies to the NHS medicines page for tirzepatide, which is the most accessible plain-English summary of how it works, what to expect, and when to get help.

For context on the cost of private treatment, the Eli Lilly price increase page covers what happened to UK list prices from September 2025, which is useful background if you're comparing provider costs.

When the name comes up in a clinical conversation

If you're discussing tirzepatide with a prescriber, a pharmacist or a GP, saying "tir-ZEP-a-tide" or simply "Mounjaro" will both be understood without hesitation. The two terms are interchangeable in conversation; clinicians use them interchangeably themselves. What matters far more than pronunciation is the clinical detail, your health history, current BMI, any medications you take, and whether tirzepatide is appropriate for you.

At nume, a GPhC-registered Independent Prescriber reads every consultation personally before any treatment is approved. There's no algorithm making that call. If you'd like to explore whether tirzepatide could be suitable, the how tirzepatide works page covers the mechanism in plain terms, and the weight-loss treatment overview sets out the full picture of what's available. When you're ready, you can speak to our prescribers through a free consultation, same day, no waiting list, no guesswork about eligibility.